Latest news with #KneatGx
Yahoo
28-05-2025
- Business
- Yahoo
Kneat Announces Results of Voting at Annual General Meeting
LIMERICK, Ireland, May 28, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTC: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, announced results from its Annual General Meeting of Shareholders (the "2025 AGM"), which took place today. All director nominees were elected to the board of directors (the "Kneat Board") and KPMG LLP was appointed as auditors, as further described in the related Management Information Circular dated April 23, 2025 (the "Circular"). The detailed results of voting at the 2025 AGM are set out below: 1. Election of Directors Shareholders voted to elect all five directors nominated to the Kneat Board. Name of Nominee Number of Votes Cast Votes "For" Votes "For" % Ian Ainsworth 48,954,620 47,616,238 97.27% Edmund Ryan 48,954,620 48,954,095 100.00% Wade K. Dawe 48,954,620 47,008,047 96.02% Nutan Behki 48,954,620 47,644,301 97.32% Carol Leaman 48,954,620 48,939,765 99.97% 2. Re-Appointment of Auditors Shareholders voted to approve management's recommendation that KPMG LLP be re-appointed as auditors of the Company, to hold office until the close of the next annual meeting of shareholders, and to authorize the Company to fix their remuneration for the forthcoming year. Number of Votes Cast Votes "For" Votes "For" % 48,954,620 48,908,449 99.91% Final voting results on all matters voted at the 2025 AGM have been filed with Canadian securities regulators. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end to end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-706-9074E: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
Global Diagnostics Leader Selects Kneat
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry ('the Company') has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the healthcare industry. Its diagnostic solutions are used by hospitals, laboratories and physicians' offices around the world for routine and complex clinical testing. As a division of a larger life sciences organization with more than 60,000 employees, the Company will use Kneat Gx initially to digitize its equipment validation process. 'The quality of our platform, its maturity in the market and the expertise and commitment of our team enabled this win,' said Eddie Ryan, Kneat's CEO. 'Adopting Kneat is another step in this customer's longstanding commitment to continuous improvement. We look forward to working with them to deliver the efficiency and compliance benefits that characterize Kneat.' As the many segments of life sciences seek to improve quality, compliance and speed to market, more and more companies are shifting from a manual, paper-based validation process to one that is streamlined and harmonized through digitalization. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: investors@
Yahoo
15-05-2025
- Business
- Yahoo
Global Diagnostics Leader Selects Kneat
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry ('the Company') has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the healthcare industry. Its diagnostic solutions are used by hospitals, laboratories and physicians' offices around the world for routine and complex clinical testing. As a division of a larger life sciences organization with more than 60,000 employees, the Company will use Kneat Gx initially to digitize its equipment validation process. 'The quality of our platform, its maturity in the market and the expertise and commitment of our team enabled this win,' said Eddie Ryan, Kneat's CEO. 'Adopting Kneat is another step in this customer's longstanding commitment to continuous improvement. We look forward to working with them to deliver the efficiency and compliance benefits that characterize Kneat.' As the many segments of life sciences seek to improve quality, compliance and speed to market, more and more companies are shifting from a manual, paper-based validation process to one that is streamlined and harmonized through digitalization. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: investors@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
07-05-2025
- Business
- Yahoo
Kneat Announces Record Revenue for First Quarter 2025
Also in May 2025, Kneat announced the expansion of its executive leadership team with the addition of a Chief Innovation Officer Role. Co-founder and Chief Product Officer Kevin Fitzgerald will transition out of his current role and into the Chief Innovation Officer role on June 9. Donal O'Sullivan, an executive with extensive software development and product management leadership, will join Kneat at that time as Chief Product Officer. In May 2025, Kneat saw record attendance at VALIDATE, its annual event convening validation and quality professionals from around the world. One of the world's largest events for validation experts to discover, share and apply validation technologies, regulations, and best practices, VALIDATE enabled participants to witness the power of the Kneat Gx platform. Also in January 2025, Kneat announced that a European-headquartered leader in specialty therapeutics selected Kneat for commissioning, qualification and validation of its manufacturing equipment and facilities. In January 2025, Kneat announced that it has partnered with Capgemini. The collaboration brings together Capgemini's expertise in enterprise IT systems integration with Kneat's digital validation platform, Kneat Gx. The partnership is designed to enable life sciences companies to seamlessly deploy Kneat Gx enterprise-wide; connect with core systems such as ERP, QMS, and DMS; and scale digital validation processes with ease. 1 ARR is a supplementary measure. EBITDA and Adjusted EBITDA are non-IFRS measures and are not recognized, defined or standardized measures under IFRS. These measures are defined in the 'Supplementary and Non-IFRS Measures' section of this news release. Adjusted EBITDA 1 in the first quarter of 2025 was $2.3 million, compared with $0.6 million for the first quarter of 2024. EBITDA 1 in the first quarter of 2025 was $5.9 million, compared with ($0.5) million for the first quarter of 2024. Gross margin in the first quarter of 2025 was 74%, as it was in the first quarter of 2024. SaaS revenue for the first quarter of 2025 grew 42% to $13.8 million, versus $9.7 million for the first quarter of 2024. Total revenues increased 37% to $14.7 million in the first quarter of 2025, compared to $10.8 million for the first quarter of 2024. 'Kneat is off to a solid start in 2025, both in terms of continued strong growth and progress toward profitability. We are encouraged by our customers' continued intention to orchestrate their validation processes enterprise-wide; and we are committed to enhancing the Kneat Gx platform to help them complete their vision for efficiency, speed and trust in their validation processes.' LIMERICK, Ireland, May 07, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTC: KSIOF) ('Kneat' or the 'Company') a leader in digitizing and automating validation and quality processes, today announced financial results for the three months ended March 31, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated. Story Continues 'Kneat closed the quarter with ample cash and a strong balance sheet. Our high-retention customer base continues to grow, and we remain confident in our financial outlook.' - Hugh Kavanagh, Chief Financial Officer of Kneat. Quarterly Conference Call Eddie Ryan, Chief Executive Officer of Kneat, and Hugh Kavanagh, Chief Financial Officer of Kneat, will host a conference call to discuss Kneat's first quarter of 2025 results and hold a Q&A session for analysts and investors via webcast on May 08, 2025, at 9:00 a.m. ET. Interested parties can register for the live webcast via the following link: Register Here Supplementary and Non-IFRS Financial Measures The Company uses supplementary financial measures as key performance indicators in its MD&A and other communications. Management uses both IFRS measures and supplementary, non-IFRS financial measures as key performance indicators when planning, monitoring and evaluating the Company's performance. Annual Recurring Revenue ('ARR') Kneat management use ARR to evaluate and assess the Company's performance, identify trends affecting its business, formulate financial projections and make financial decisions. The Company believes that ARR is a useful metric for investors as it provides a measure of the value of the recurring revenue at a point in time (end date of the relevant quarter). ARR is based on signed agreements and indicates the level of recurring revenue that the Company would anticipate reporting in a 12-month period based on the full agreed annual SaaS and maintenance fees for existing customers. In specific circumstances, the Company may utilize pricing incentives for limited contract periods. ARR is used by Kneat to assess the expected recurring revenues from the customers that are live on the Kneat Gx platform at the end of the period. ARR is calculated using the licenses delivered to customers at the period end, multiplied by the expected customer retention rate of 100% and multiplied by the full annual SaaS license or maintenance fee. Since many of the customer contracts are in currencies other than the Canadian dollar, the Canadian dollar equivalent is calculated using the related period end exchange rate multiplied by the contracted currency amount. Earnings before Interest, Taxes, Depreciation and Amortization ('EBITDA') EBITDA is calculated as net income (loss) attributable to excluding interest income (expense), provision for income taxes, depreciation and amortization. We provide and use this non-IFRS measure of our operating performance to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures and to inform financial comparisons with other companies. A reconciliation of EBITDA to IFRS financial measures is provided in the financial statements accompanying this press release. Adjusted Earnings before Interest, Taxes, Depreciation and Amortization ('Adjusted EBITDA') Adjusted EBITDA is calculated as net income (loss) attributable to excluding interest income (expense), provision for income taxes, depreciation and amortization, foreign exchange gain (loss) and stock-based compensation expense. We provide and use this non-IFRS measure of our operating performance to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures and to inform financial comparisons with other companies. A reconciliation of Adjusted EBITDA to IFRS financial measures is provided in the financial statements accompanying this press release. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, our ability to win business from new customers and expand business from existing customers, our expected use of the net proceeds from the IPF Facility and the public equity financing completed in both February and October 2024 and the anticipated effects thereof on the business and operations of the company, and the compliance of Kneat's platform under regulatory audit and inspection. These and other assumptions, risks and uncertainties may cause Kneat's actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. Material risks and uncertainties relating to our business are described under the headings 'Cautionary Note Regarding Forward-Looking Statements and Information' and 'Risk Factors' in our MD&A dated May 7, 2025, under the heading 'Risk Factors' in our Annual Information Form dated February 26, 2025 and in our other public documents filed with Canadian securities regulatory authorities, which are available at Forward-looking statements are provided to help readers understand management's expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kneat assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For further information: Katie Keita, Kneat Investor Relations P: + 1 902-706-9074 E: Unaudited Condensed Interim Consolidated Statements of Income/(Loss) and Comprehensive Income/(Loss) Three-month period ended March 31, 2025 Three-month period ended March 31, 2024 $ $ Revenue SaaS license fees 13,805,973 9,718,501 Maintenance fees 22,095 70,589 Professional services and other 919,573 977,910 Total Revenue 14,747,641 10,767,000 Cost of revenue (3,823,145 ) (2,834,015 ) Gross profit 10,924,496 7,932,985 Gross margin 74% 74% Expenses Research and development (4,698,665 ) (4,045,548 ) Sales and marketing (5,116,477 ) (4,031,684 ) General and administrative (2,511,629 ) (2,105,589 ) Total Expenses (12,326,771 ) (10,182,821 ) Operating loss (1,402,275 ) (2,249,836 ) Finance expense (888,545 ) (867,451 ) Interest income 198,639 35,076 Foreign exchange gain (loss) 4,262,600 (238,763 ) Income (loss) before income taxes 2,170,419 (3,320,974 ) Income tax expense (24,430 ) (15,887 ) Net income (loss) for the period 2,145,989 (3,336,861 ) Other comprehensive (loss) income Foreign currency translation adjustment to presentation currency (1,998,521 ) 190,894 Comprehensive income (loss) for the period 147,468 (3,145,967 ) Earnings (loss) per share: Basic and diluted 0.02 (0.04 ) Weighted-average number of common shares outstanding: Basic 94,221,072 81,005,029 Diluted 97,738,261 81,005,029 Reconciliation: Net income (loss) for the period 2,145,989 (3,336,861 ) Finance expense 888,545 867,451 Interest income (198,639 ) (35,076 ) Income tax expense 24,430 15,887 Depreciation charge 177,001 191,221 Amortization of intangible assets charge 2,846,747 1,834,211 EBITDA 5,884,073 (463,167 ) Adjustments to EBITDA Foreign exchange gain/loss (4,262,600 ) 238,763 Stock based compensation 697,019 812,173 Adjusted EBITDA 2,318,492 587,769 inc. Unaudited Condensed Interim Consolidated Statements of Financial Position March 31, 2025 December 31, 2024 $ $ Assets Current assets Cash 74,132,378 58,889,572 Amounts receivable 10,958,849 18,377,009 Prepayments 2,081,208 1,870,095 87,172,435 79,136,676 Non-current assets Amounts receivable 3,544,947 2,368,006 Property and equipment 6,914,606 6,782,179 Intangible asset 39,158,433 36,290,869 Total Assets 136,790,421 124,577,730 Liabilities Current liabilities Accounts payable and accrued liabilities 9,080,206 8,580,104 Contract liabilities 31,037,419 21,631,416 Loan payable 5,122,755 4,116,723 Lease liabilities 386,207 434,096 45,626,587 34,762,339 Non-current liabilities Contract liabilities 42,339 33,393 Loan payable and accrued interest 18,384,423 19,038,203 Lease liabilities 5,800,955 5,671,952 Total Liabilities 69,854,304 59,505,887 Equity Shareholders' equity 66,936,117 65,071,843 Total Liabilities and Equity 136,790,421 124,577,730 inc. Unaudited Condensed Interim Consolidated Statement of Cash Flows Three-month period ended March 31, 2025 Three-month period ended March 31, 2024 Operating activities $ $ Net income (loss) for the period 2,145,989 (3,336,861 ) Charges to loss not involving cash: Depreciation of property and equipment 177,001 191,221 Share-based compensation 697,019 812,173 Interest expense 842,563 867,451 Tax expense 24,430 15,887 Amortization of the intangible asset 2,846,747 1,834,211 Amortization of loan issuance costs 45,982 36,957 Foreign exchange (gain) loss (4,262,600 ) 238,763 Increase in non-current contract liabilities 7,553 58,319 Net change in non-cash operating working capital related to operations 14,951,929 7,684,397 Net cash provided by operating activities 17,476,613 8,402,518 Financing activities Proceeds received from public equity financing - 20,000,110 Share issuance costs associated with public equity financing - (1,626,257 ) Payment of principal and interest on loans payable (1,348,282 ) (621,996 ) Proceeds from the exercise of stock options 774,591 641,700 Repayment of lease liabilities (192,894 ) (181,158 ) Net cash (used in)/provided by financing activities (766,585 ) 18,212,399 Investing activities Additions to the intangible asset (5,157,268 ) (4,515,850 ) Additions to property and equipment (62,917 ) (8,163 ) Collection of research and development tax credits 1,850,702 - Net cash used in investing activities (3,369,483 ) (4,524,013 ) Effects of foreign exchange rates on cash 1,902,261 164,519 Net change in cash during the period 15,242,806 22,255,423 Cash – Beginning of period 58,889,572 15,252,526 Cash – End of period 74,132,378 37,507,949
Yahoo
05-05-2025
- Business
- Yahoo
Kneat Expands Executive Leadership Team
Co-founder Kevin Fitzgerald Becomes Chief Innovation Officer as Donal O'Sullivan Joins as Chief Product Officer LIMERICK, Ireland, May 05, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTC: KSIOF) ('Kneat' or the 'Company') a leader in digitizing and automating validation and quality processes, today announced the expansion of its executive leadership team. As a product-led company that continues to scale for efficiencies and satisfy the growing demand from global customers, Kneat's innovation and product development are critical pillars for success. To optimise product operational excellence and strategic planning, Kneat is expanding its senior management team to provide the necessary strategic leadership, governance and cadence as it grows. In early June, Kevin Fitzgerald, Kneat co-founder and Chief Product Officer, will step out of his current role and not seek re-election to the Board of Directors to take on the newly created role of Chief Innovation Officer. This will enable Kevin to dedicate his focus and attention on the strategic vision and innovation of Kneat product, ensuring clarity of product definition and alignment of product requests and features to that vision. At that time, Donal O'Sullivan will join Kneat to fill the role of Chief Product Officer. Donal has more than 25 years' experience in software development leadership roles. Donal joins Kneat from My Compliance Office where he is currently acting as CPO. Prior to this, Donal served as Global Head of Analytics Product Management in PICO Ltd for four years, having previously served in Corvil for 18 years as Head of product Management and Director of Product Management. His responsibilities included leading the Product Management team, Product Marketing, Sales Enablement, Pricing and Bundling product, as well as managing the Corvil Portfolio to deliver significant growth. PICO, a provider of IT performance and operational analytics systems, acquired Corvil, and Donal successfully merged the best of Corvil's product capabilities with PICO's strong record of service delivery. 'Donal's varied and extensive software development and product management leadership experience will be hugely beneficial as we become a bigger company. With Donal on board and Kevin able to focus exclusively on developing the Kneat Gx platform to its full potential, we are better equipped to capture the exceptional opportunity in front of us today.' – Eddie Ryan, Chief Executive Officer of Kneat. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, our ability to win business from new customers and expand business from existing customers, our expected use of the net proceeds from the IPF Facility and the public equity financing completed in both February and October 2024 and the anticipated effects thereof on the business and operations of the company, and the compliance of Kneat's platform under regulatory audit and inspection. These and other assumptions, risks and uncertainties may cause Kneat's actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-706-9074E: in to access your portfolio
